Agree.net – Lifestyle

Author: Neuvasq Biotechnologies

Neuvasq Presents Data Showcasing Promising Novel Multispecific Gpr124-Targeting Antibodies for Blood Retina Barrier Restoration at ARVO 2026

May 5, 2026